StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)

Close on Nov 18, 2026Market cap $1.56BP/E –Yield –

Earnings

Enovis's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$559.00M
+1.8% on a year earlier
adjusted net earnings per diluted share, Q3 FY2026
$0.88
$0.75 a year earlier
Latest guidance
Issued
Nov 5, 2026 · 4 items

Quarterly results

Revenue and earnings per share from each of Enovis's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 25, 2027Expected–––––
Q3 FY2026ended Oct 2, 2026Nov 5, 2026before the open$559.00M+1.8%$0.02$0.88Release
Q2 FY2026ended Jul 3, 2026Aug 6, 2026before the open$583.00M+3.2%-$0.02$0.90Release
Q1 FY2026ended Apr 3, 2026May 7, 2026before the open$589.00M+5.4%-$0.15$0.89Release
Q4 FY2025ended Dec 31, 2025Feb 26, 2026before the open$576.00M+2.7%-$9.07$0.95Release
Q3 FY2025ended Oct 3, 2025Nov 6, 2025before the open$549.00M+8.7%-$9.99$0.75Release
Q2 FY2025ended Jul 4, 2025Aug 7, 2025before the open$565.00M+7.6%-$0.64$0.79Release
Q1 FY2025ended Apr 4, 2025May 8, 2025before the open$559.00M+8.3%-$0.98$0.81Release
Q4 FY2024ended Dec 31, 2024Feb 26, 2025before the open$561.00M+23.3%-$12.06$0.98Release
Q3 FY2024ended Sep 27, 2024Nov 6, 2024before the open$505.00M+20.8%-$0.61$0.73Release
Q2 FY2024ended Jun 28, 2024Aug 7, 2024before the open$525.00M+22.4%-$0.34$0.62Release
Q1 FY2024ended Mar 29, 2024May 2, 2024before the open$516.00M+27.1%-$1.32$0.50Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Enovis's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
organic revenue growthnon-GAAPFY2026+5%–NewNov 5, 2026
organic revenue growthFY2026+4% – +6%+4% – +6%ReaffirmedAug 6, 2026
organic revenue growthnon-GAAPFY2026+4% – +6%–NewFeb 26, 2026
RevenueFY2026$2.31B – $2.37B$2.31B – $2.37BReaffirmedAug 6, 2026
Revenue guidanceGAAPFY2026$2.32B – $2.35B–NewNov 5, 2026
Adjusted EBITDAnon-GAAPFY2026$425.00M – $435.00M$425.00M – $435.00MReaffirmedAug 6, 2026
Adjusted EBITDA guidancenon-GAAPFY2026$428.00M – $438.00M–NewNov 5, 2026
adjusted earnings per sharenon-GAAPFY2026$3.52 – $3.73$3.52 – $3.73ReaffirmedAug 6, 2026
Full-year adjusted earnings per share guidancenon-GAAPFY2026$3.58 – $3.79–NewNov 5, 2026
free cash flow conversionFY202625%–NewAug 6, 2026
free cash flow conversionnon-GAAPFY202625%–NewMay 7, 2026

Guidance vs results

The last range Enovis gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025adjusted earnings per share$3.10 – $3.25$3.30Σ4QAbove range
FY2025Revenue$2.24B – $2.27B$2.25BΣ4QWithin range

Guidance history

Every forecast Enovis put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026Adjusted EBITDA guidanceFY2026$428.00M – $438.00MNew
Nov 5, 2026Full-year adjusted earnings per share guidanceFY2026$3.58 – $3.79New
Nov 5, 2026Revenue guidanceFY2026$2.32B – $2.35BNew
Nov 5, 2026organic revenue growthFY2026+5%New
Aug 6, 2026Adjusted EBITDAFY2026$425.00M – $435.00MReaffirmed
Aug 6, 2026adjusted earnings per shareFY2026$3.52 – $3.73Reaffirmed
Aug 6, 2026free cash flow conversionFY202625%New
Aug 6, 2026organic revenue growthFY2026+4% – +6%Reaffirmed
Aug 6, 2026RevenueFY2026$2.31B – $2.37BReaffirmed
May 7, 2026Adjusted EBITDAFY2026$425.00M – $435.00MReaffirmed
May 7, 2026adjusted earnings per shareFY2026$3.52 – $3.73Reaffirmed
May 7, 2026free cash flow conversionFY202625%New
May 7, 2026RevenueFY2026$2.31B – $2.37BReaffirmed
May 7, 2026organic revenue growthFY2026+4% – +6%New
Feb 26, 2026Adjusted EBITDAFY2026$425.00M – $435.00MNew
Feb 26, 2026adjusted earnings per shareFY2026$3.52 – $3.73New
Feb 26, 2026RevenueFY2026$2.31B – $2.37BNew
Feb 26, 2026organic revenue growthFY2026+4% – +6%New
Nov 6, 2025Adjusted EBITDAFY2025$395.00M – $405.00MNew
Nov 6, 2025adjusted earnings per shareFY2025$3.10 – $3.25New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Enovis filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Results
  5. Results
  6. Results
  7. Update
  8. Results
  9. Results
  10. Results
  11. Update
  12. Results
  13. Update
  14. Update
  15. Results

See a number that looks wrong?